Swiss chocolate maker Lindt & Spruengli said it expected its organic sales to fall around 5-7% this year before bouncing back next year after COVID-related store closures hit sales and profit in the first half of 2020.
FILE PHOTO: Lindor chocolate eggs of Swiss chocolatier Lindt & Spruengli are displayed during the annual news conference in Kilchberg, Switzerland March 3, 2020. REUTERS/Arnd Wiegmann
Chocolate makers have been facing soft demand as many grocery shoppers focused on stocking up on essential supplies and made fewer impulse purchases during the COVID-19 pandemic. The company said the outlook was based on the assumption of no more large-scale lockdowns and a Christmas business similar to last year.
Sales were particularly affected by the restrictions on retail trade and the temporary closure of around 500 of Lindt’s own shops over Easter, normally a peak season for sales.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Forbes Insights: How UnitedHealth Group Harnesses Data For A Better Covid-19 ResponseSince the start of the pandemic, UnitedHealth Group has continued to adapt to better serve at-risk patients. Here’s how Sponsored by Teradata
Weiterlesen »
Christopher Nolan's new movie 'Tenet' delayed for third time as COVID-19 cases spikeThe delay of 'Tenet' comes as a disappointment to U.S. movie theater chains, many of which have used the film's release date as a reference point for their reopening plans.
Weiterlesen »
Two Covid-19 vaccines 'produce immune response' in trialsHopes grow of a potential vaccine for the novel coronavirus after two trials, each by British and Chinese researchers, showed most volunteers had developed widespread antibody immune response.
Weiterlesen »
Oxford COVID-19 vaccine trials show 'promising numbers'Oxford coronavirus vaccine induces strong immune response, early trial results suggest. BhadeliaMD: 'These are really promising numbers so when they are taken into trials, they might show results. It’s all numbers though.'
Weiterlesen »
Pfizer-BioNTech potential COVID-19 vaccine shows promise in additional dataGerman biotech firm BioNTech and U.S. drugmaker Pfizer on Monday reported additional data from their experimental COVID-19 vaccine that showed it was safe and induced an immune response in patients.
Weiterlesen »